Supplemental material
Leukemia & Lymphoma
Volume 64, 2023 - Issue 2
Articles
Adherence to quality indicators in chronic myeloid leukemia care: results from a population-based study in The Netherlands
Geneviève I.C.G. Ectora Department of Hematology, Radboud University Medical Center, Nijmegen, NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0002-1558-944X
https://orcid.org/0000-0002-1558-944X, , Avinash G. Dinmohamedc Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands;d Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands;e Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands;f Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlandshttps://orcid.org/0000-0002-4767-6716
https://orcid.org/0000-0002-4767-6716, Mels Hoogendoorng Department of Hematology, Medical Center Leeuwarden, on behalf of the HemoBase Population Registry Consortium, Leeuwarden, Netherlandshttps://orcid.org/0000-0001-8032-2592
https://orcid.org/0000-0001-8032-2592, Peter E. Westerweelb Department of Hematology, Albert Schweitzer Hospital, Dordrecht, Netherlandshttps://orcid.org/0000-0002-0746-7039
https://orcid.org/0000-0002-0746-7039, Rosella P.M.G. Hermensh Department of IQ Healthcare, Radboud Institute for Healthcare Sciences (RIHS), Radboud University Medical Center, Nijmegen, Netherlandshttps://orcid.org/0000-0001-7624-7120
https://orcid.org/0000-0001-7624-7120 & Nicole M.A. Blijlevensa Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlandshttps://orcid.org/0000-0002-1801-2072
https://orcid.org/0000-0002-1801-2072 show all